Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Association between ibrutinib treatment and hypertension | Synapse

July 1, 2021Open Access

Association between ibrutinib treatment and hypertension

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Ibrutinib is associated with the development of hypertension and worsening of blood pressure. Cardiologists and oncologists must be aware of this cardiotoxicity to allow timely management of blood pressure elevations.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Lee et al. (Thu,) studied this question.

synapsesocial.com/papers/69df6e4258b92af24d7a18eb https://doi.org/https://doi.org/10.1136/heartjnl-2021-319110

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Tyrosine Kinase Inhibitor-Induced Hypertension2018 · 89 citations
2Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor2019 · 66 citations
3Statistical Methods in Medical Research2002 · 1,629 citations
4Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial2010 · 1,869 citations
5Anti-VEGF-Induced Hypertension: a Review of Pathophysiology and Treatment Options2016 · 54 citations